2016 ACBS Landline-Cellphone Combined Prevalence Tables

BRFSS Asthma Call-back Survey Prevalence TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2016.

Table 9 LLCP
State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Arizona 331 33.1 4.5 (24.3 – 41.9) 352 31.1 4.3 (22.7 – 39.5)
California 234 32.5 3.9 (24.9 – 40.1) 263 30.0 3.6 (22.9 – 37.1)
Connecticut 294 39.3 4.3 (30.9 – 47.7) 315 36.8 4.1 (28.8 – 44.8)
Florida 888 22.2 3.1 (16.1 – 28.3) 967 21.2 2.9 (15.5 – 26.9)
Georgia 150 28.5 5.1 (18.5 – 38.5) 157 26.8 4.8 (17.4 – 36.2)
Hawaii 218 30.7 4.6 (21.7 – 39.7) 248 28.4 4.3 (20.0 – 36.8)
Illinois 168 31.7 4.6 (22.7 – 40.7) 175 29.8 4.5 (21.0 – 38.6)
Indiana 436 31.9 3.3 (25.4 – 38.4) 466 29.8 3.1 (23.7 – 35.9)
Iowa 177 29.3 5.0 (19.5 – 39.1) 187 29.5 4.8 (20.1 – 38.9)
Kansas 370 29.8 3.7 (22.5 – 37.1) 390 30.9 3.6 (23.8 – 38.0)
Maine 546 35.8 3.5 (28.9 – 42.7) 578 34.6 3.3 (28.1 – 41.1)
Massachusetts 201 40.3 4.8 (30.9 – 49.7) 216 38.0 4.6 (29.0 – 47.0)
Michigan 614 36.3 2.8 (30.8 – 41.8) 657 35.6 2.7 (30.3 – 40.9)
Minnesota 551 29.0 2.3 (24.5 – 33.5) 604 25.8 2.1 (21.7 – 29.9)
Missouri 252 45.6 5.4 (35.0 – 56.2) 280 41.1 5.5 (30.3 – 51.9)
Montana 181 33.5 5.3 (23.1 – 43.9) 194 34.6 5.2 (24.4 – 44.8)
Nebraska 440 28.1 3.6 (21.0 – 35.2) 466 27.9 3.4 (21.2 – 34.6)
Nevada 151 24.8 5.9 (13.2 – 36.4) 157 24.1 5.7 (12.9 – 35.3)
New Hampshire 203 38.2 5.1 (28.2 – 48.2) 220 34.7 4.8 (25.3 – 44.1)
New Jersey 255 24.7 4.2 (16.5 – 32.9) 291 23.2 3.8 (15.8 – 30.6)
New Mexico 201 31.0 4.5 (22.2 – 39.8) 210 30.0 4.4 (21.4 – 38.6)
New York 425 32.4 4.6 (23.4 – 41.4) 460 30.2 4.2 (22.0 – 38.4)
Ohio 423 28.0 3.8 (20.6 – 35.4) 447 27.4 3.6 (20.3 – 34.5)
Oklahoma 145 36.0 7.2 (21.9 – 50.1) 153 33.9 7.2 (19.8 – 48.0)
Oregon 145 41.4 4.7 (32.2 – 50.6) 165 37.5 4.3 (29.1 – 45.9)
Pennsylvania 249 33.4 4.1 (25.4 – 41.4) 260 32.5 3.9 (24.9 – 40.1)
Rhode Island 175 30.3 5.2 (20.1 – 40.5) 188 28.6 4.8 (19.2 – 38.0)
Texas 348 29.4 4.7 (20.2 – 38.6) 373 24.9 4.2 (16.7 – 33.1)
Utah 300 30.3 3.7 (23.0 – 37.6) 333 28.5 3.5 (21.6 – 35.4)
Vermont 231 32.7 3.9 (25.1 – 40.3) 243 31.8 3.8 (24.4 – 39.2)
Wisconsin 203 32.9 4.4 (24.3 – 41.5) 220 31.7 4.2 (23.5 – 39.9)
Puerto Rico 284 18.7 3.0 (12.8 – 24.6) 326 17.8 2.8 (12.3 – 23.3)
32 states / area 9,789 31.6 1.0 (29.6 – 33.6) 10,561 29.6 1.0 (27.6 – 31.6)
Median 31.8 30.0
Range 18.7-45.6 17.8-41.1

 
 

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline and cell phone combined sample size excludes “DK/Refused”

§ Standard error

Confidence interval

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2016/pdf/sdq_report_acbs_16-508.pdfpdf icon